Clinical Trials
7
Active:4
Completed:1
Trial Phases
2 Phases
Phase 1:5
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (71.4%)Phase 2
2 (28.6%)Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- KeyBioscience AG
- Target Recruit Count
- 600
- Registration Number
- NCT06833749
- Locations
- 🇨🇿
Pratia Brno, s.r.o, Brno, Czech Republic
🇨🇿L.K.N. Artrocentrum, Hlučín, Czech Republic
🇨🇿Medical Plus, s.r.o, Hradiště, Czech Republic
A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM
Phase 1
Terminated
- Conditions
- Type II Diabetes Mellitus
- Interventions
- Drug: Daily injection of KBP/placebo for up to 28 days
- First Posted Date
- 2019-04-08
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- KeyBioscience AG
- Target Recruit Count
- 25
- Registration Number
- NCT03907202
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes
Phase 2
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: Daily injection of KBP/placebo for 12 weeks as add-on to metformin
- First Posted Date
- 2017-07-26
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- KeyBioscience AG
- Target Recruit Count
- 255
- Registration Number
- NCT03230786
- Locations
- 🇨🇿
Vdoviak Miroslav MUDr. - Interní Ambulance, Karlovy Vary, Czechia
🇨🇿General University Hospital, Prague 2, Czechia
🇨🇿Institute for Clinical and experimental Medicine, Praha 4, Czechia
News
No news found